25 /100
LOW RISK
Score updated Jul 13, 2026

VMD — Viemed Healthcare, Inc. Dilution Risk Tracker

Track VMD dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track VMD — Get alerts when the score changes →

As of July 13, 2026, Viemed Healthcare, Inc. (VMD) has a DilutionWatch DilutionScore of 25/100, rated LOW dilution risk. Viemed Healthcare, Inc. has a market capitalization of $377.23M, 38.34M shares outstanding, 148 institutional holders tracked. Key dilution vectors include approximately 999 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
0
📊 Float Risk
22
⚠️ Warrant Exposure
40
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for VMD.
🔔 Track VMD — Get forecast alerts →

💹 Market Data

Market Cap$377.23M
Shares Outstanding38.34M
Float30.25M
Cash$9.76M
Debt$9.21M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 23.2% shares (2026Q1 vs prior)
148 institutional holders · 29.59M shares
#1 BlackRock, Inc. 4.62M shares
#2 GOLDMAN SACHS GROUP INC 2.87M shares
#3 Forager Capital Management, LLC 2.83M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest519.1K
Days to Cover1.2
% of Float1.7%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Jul 07, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for VMD Shareholders

Viemed Healthcare, Inc. (VMD) has a DilutionScore of 25/100, rated Low dilution risk. At this score level, DilutionWatch's real-time EDGAR monitoring shows limited near-term dilution signals. This does not mean zero dilution risk — shelf registrations can be filed and activated quickly — but the current filing profile shows no major outstanding dilution programs. Score as of July 13, 2026.

DilutionWatch's EDGAR monitoring for VMD shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for VMD in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for VMD alongside comparable low-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track VMD Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking VMD — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for VMD
📊 VMD FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 VMD Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.